Artificial Intelligence in Drug Discovery Market – Growth Outlook, Trends, and Forecast (2024–2032)
The Artificial Intelligence in Drug Discovery Market is experiencing exponential growth, fueled by increasing demand for faster, more cost-effective drug development and rising complexity in disease treatment. Valued at USD 1.92 billion in 2024, the market is projected to reach USD 15.50 billion by 2032, growing at a CAGR of 29.89% from 2025 to 2032. AI technologies, including machine learning, deep learning, and natural language processing, are transforming the drug discovery process by enabling rapid identification of drug candidates, predicting molecular interactions, and optimizing preclinical and clinical trial phases.